The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosis
Open accessAbstract
INTRODUCTION: Advances in molecular pathogenesis suggest that the chronic inflammation is a shared mechanism in the initiation and progression of multiple neurodegenerative diseases with diverse clinical manifestations such as Alzheimer's disease (AD) and Multiple sclerosis (MS). Restricted cell renewal and regenerative capacity make the neural tissues extremely vulnerable to the uncontrolled inflammatory process leading to irreversible tissue damage. AREAS COVERED: A predominant consequence of increased inflammatory signaling is the upregulation of the transcription factor, NF-κB with subsequent neuroprotective or deleterious effects depending on the strength of the signal and the type of NF-κB dimers activated. We discuss the interplay between neuroinflammation and neurodegeneration keeping in focus NF-κB signaling as the point of convergence of multiple pathways associated with the development of the neurodegenerative pathologies, AD and MS. EXPERT OPINION: Considerable interest exists in developing efficient NF-κB inhibitors for neurodegenerative diseases. The review includes an overview of natural compounds and rationally designed agents that inhibit NF-κB and mediate neuroprotection in AD and MS. The key chemical moieties of the natural and the synthetic compounds provide efficient leads for the development of effective small molecule inhibitors that selectively target NF-κB activation; this would result in the desired benefit to risk therapeutic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuroinflammation is one of the major factors of AD and other disorders related to cholinergic transmission. It can be attenuated by reducing the expression of NF-κB-p65 via NLRP3 pathways.”
From Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy (2021) · cites this paper as [142]
In the citing paper
“Thus targeting the transcription factor (NF-κβp65) could be the novel approach for the treatment of AD.”
From Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy (2021) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, P., Su, C., Li, R., Wang, H., Ren, Y., Sun, H., Yang, J., Sun, J., Shi, J., Tian, J., et al. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23322 · Cited by 65
RetractedMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,684
Kauppinen, A., Suuronen, T., Ojala, J. O., Kaarniranta, K., & Salminen, A. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.007 · Cited by 1,016
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H., & Hong, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 852
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Glucocorticoids increase amyloid-β and tau pathology in a mouse model of alzheimer’s disease
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2797-06.2006 · Cited by 623
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2642 · Cited by 619
Cited by
Sorted by citations
Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Giridharan, S., & Srinivasan, M. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s140188 · Cited by 686
microRNA dysregulation in neurodegenerative diseases: A systematic review
Juźwik, C. A., S. Drake, S., Zhang, Y., Paradis-Isler, N., Sylvester, A., Amar-Zifkin, A., Douglas, C., Morquette, B., Moore, C. S., & Fournier, A. E. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101664 · Cited by 426
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Sun, E., Motolani, A., Campos, L., & Lu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168972 · Cited by 381
Targeting Transcription Factors for Cancer Treatment
Lambert, M., Jambon, S., Depauw, S., & David‐Cordonnier, M. (2018) · Molecules · doi:10.3390/molecules23061479 · Cited by 359
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Fonseca‐Santos, B., Chorilli, M., & Gremião, M. P. D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 320
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 307
Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
Fão, L., Mota, S. I., & Rego, A. C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100942 · Cited by 281
Green tea polyphenols and their potential role in health and disease
Afzal, M., Safer, A.-M., & Menon, M. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0236-1 · Cited by 215
Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer’s and Parkinson’s Disease
Caruana, M., Cauchi, R. J., & Vassallo, N. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00031 · Cited by 164
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
Jha, N. K., Jha, S. K., Kar, R., Nand, P., Swati, K., & Goswami, V. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14687 · Cited by 163
Bhattacharjee, S., Zhao, Y., Dua, P., Rogaev, E. I., & Lukiw, W. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150211 · Cited by 147
Zhao, F., Zhang, J., & Chang, N. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.046 · Cited by 128
Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?
Mamun, A. A., Shao, C., Geng, P., Wang, S., & Xiao, J. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90982 · Cited by 134
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease
Sivamaruthi, B. S., Raghani, N. R., Chorawala, M. R., Bhattacharya, S., Prajapati, B. G., Elossaily, G. M., & Chaiyasut, C. (2023) · Biomedicines · doi:10.3390/biomedicines11092587 · Cited by 126
Wu, J., Yu, Y., Wan, Y., Xia, J., Xu, J., Zhang, L., Liu, D., Chen, L., Tang, F., Ao, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113207 · Cited by 119
Arya, A., Chahal, R., Rao, R., Rahman, M. H., Kaushik, D., Akhtar, M. F., Saleem, A., Khalifa, S. M. A., El-Seedi, H. R., Kamel, M., et al. (2021) · Biomolecules · doi:10.3390/biom11030350 · Cited by 111
Treatment of Sjögren’s syndrome: current therapy and future directions
Fox, R. I., Fox, C. M., Gottenberg, J., & Dörner, T. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez142 · Cited by 109
On the antioxidant, neuroprotective and anti-inflammatory properties of S-allyl cysteine: An update
Colín-González, A. L., Ali, S. F., Túnez, I., & Santamarı́a, A. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.06.011 · Cited by 107
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Mekhora, C., Lamport, D. J., & Spencer, J. P. E. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105900 · Cited by 108
Olasehinde, T. A., & Olaniran, A. O. (2022) · Toxics · doi:10.3390/toxics10080417 · Cited by 101
El-Bakoush, A., & Olajide, O. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.016 · Cited by 81
Dolatshahi, M., Hameghavandi, M. H. R., Sabahi, M., & Rostamkhani, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15242 · Cited by 87
The Influence of Gut Microbiota on Neurogenesis: Evidence and Hopes
Sarubbo, F., Cavallucci, V., & Pani, G. (2022) · Cells · doi:10.3390/cells11030382 · Cited by 89
Kerr, F., Bjedov, I., & Sofola-Adesakin, O. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00297 · Cited by 80
Cui, Y., Yang, M., Wang, Y., Ren, J., Lin, P., Cui, C., Song, J., He, Q., Hu, H., Wang, K., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002247rr · Cited by 73
Huang, B., He, D., Chen, G., Ran, X., Guo, W., Kan, X., Wang, W., Liu, D., Fu, S., & Liu, J. (2018) · Food & Function · doi:10.1039/c8fo00057c · Cited by 71
Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer’s disease.
Qian, Q., Zhang, J., He, F.-P., Bao, W.-X., Zheng, T.-T., Zhou, D.-M., Pan, H.-Y., Zhang, H., Zhang, X.-Q., He, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801846r · Cited by 70
Gao, T., Jernigan, J. E., Raza, S. A., Dammer, E. B., Xiao, H., Seyfried, N. T., Levey, A. I., & Rangaraju, S. (2019) · Glia · doi:10.1002/glia.23678 · Cited by 68
Mishra, P., Mittal, A. K., Kalonia, H., Madan, S., Ghosh, S., Sinha, J. K., & Rajput, S. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729111744 · Cited by 70
Jin, Y., Zhang, Q., Qin, X., Liu, Z., Li, Z., Zhong, X., Xia, L., He, J., & Fang, B. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01681-6 · Cited by 64
Jakhmola, S., & Jha, H. C. (2021) · Virology · doi:10.1016/j.virol.2021.04.005 · Cited by 61
Fan, P., Tyagi, A. K., Agboke, F. A., Mathur, R., Pokharel, N., & Jordan, V. C. (2018) · Cell Death Discovery · doi:10.1038/s41420-017-0012-7 · Cited by 63
Impact of aging immune system on neurodegeneration and potential immunotherapies
Liang, Z., Zhao, Y., Ruan, L., Zhu, L., Jin, K., Zhuge, Q., Su, D., & Zhao, Y. L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.006 · Cited by 64
Abdi, M., Pasbakhsh, P., Shabani, M., Nekoonam, S., Sadeghi, A., Fathi, F., Abouzaripour, M., Mohamed, W. M. Y., Zibara, K., Kashani, I. R., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00417-y · Cited by 57
Zhao, Y., Pogue, A. I., & Lukiw, W. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226223 · Cited by 59
Benvenuti, L., D’Antongiovanni, V., Pellegrini, C., Antonioli, L., Bernardini, N., Blandizzi, C., & Fornai, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239199 · Cited by 56
Hsp70 and NF-kB Mediated Control of Innate Inflammatory Responses in a Canine Macrophage Cell Line
Lyu, Q., Wawrzyniuk, M., Rutten, V. P. M. G., van Eden, W., Sijts, A. J. A. M., & Broere, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186464 · Cited by 59
Gage, M., & Thippeswamy, T. (2021) · CNS Drugs · doi:10.1007/s40263-020-00787-5 · Cited by 54
Methylglyoxal Formation—Metabolic Routes and Consequences
Vašková, J., Sabolová, G., Pudelský, J., Palenčár, D., & Mičková, H. (2025) · Antioxidants · doi:10.3390/antiox14020212 · Cited by 61
Lim, H.-S., Kim, O. S., Kim, B., & Jeong, S. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.0074 · Cited by 50
Alvariño, R., Alonso, E., Lacret, R., Oves‐Costales, D., Genilloud, O., Reyes, F., Alfonso, A., & Botana, L. M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01090 · Cited by 48
Regulation of Human Brain Microvascular Endothelial Cell Adhesion and Barrier Functions by Memantine
Wang, F., Zou, Z., Gong, Y., Yuan, D., Chen, X., & Sun, T. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0917-x · Cited by 46
Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 46
Ramli, N. Z., Yahaya, M. F., Tooyama, I., & Damanhuri, H. A. (2020) · Antioxidants · doi:10.3390/antiox9101019 · Cited by 43
ATF4 selectively regulates heat nociception and contributes to kinesin-mediated TRPM3 trafficking
Xie, M.-X., Cao, X., Zeng, W., Lai, R.-C., Guo, L., Wang, J., Xiao, Y.-B., Zhang, X., Chen, D., Liu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21731-1 · Cited by 38
Chuang, K., Li, M., Lin, N., Chang, C.-H., Lu, I.-H., Pan, I.-H., Takahashi, T., Perng, M., & Wen, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5414297 · Cited by 40
He, X., Cui, L., Wang, X., Yan, Z., Li, C., Gong, S.-D., Zheng, Y., Luo, Z., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.23045 · Cited by 37
Liu, X., Wang, K., Wei, X., Xie, T., Lv, B., Zhou, Q., & Wang, X. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03227-y · Cited by 37
Xiang, N., He, M., Ishaq, M., Gao, Y., Song, F., Guo, L., Ma, L., Sun, G., Liu, D., Guo, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164471 · Cited by 36
Ren, C., Jin, J., Hu, W. M., Chen, Q., Yang, J., Wu, Y., Zhou, Y., Sun, L., Gao, W., Zhang, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754038 · Cited by 35
Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review
Mu, C., Gao, M., Xu, W., Sun, X., Chen, T., Xu, H., & Qiu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116029 · Cited by 37
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 36
Nuclear Factor-kappaB Gates Nav1.7 Channels in DRG Neurons via Protein-Protein Interaction
Xie, M.-X., Zhang, X., Xu, J., Zeng, W., Li, D., Xu, T., Pang, R., Ma, K., & Liu, X. (2019) · iScience · doi:10.1016/j.isci.2019.08.017 · Cited by 34
Gao, X., He, D., Liu, D., Hu, G., Zhang, Y., Meng, T., Su, Y., Zhou, A., Huang, B., Du, J., et al. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.151965 · Cited by 33
Li, Z., Liang, D., Ebelt, S., Gearing, M., Kobor, M. S., Konwar, C., Maclsaac, J. L., Dever, K., Wingo, A. P., Levey, A. I., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13650 · Cited by 33
Hill, J. M., Pogue, A. I., & Lukiw, W. J. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00232 · Cited by 31
Seguella, L., Capuano, R., Sarnelli, G., & Esposito, G. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1612744 · Cited by 31
Zulfugarova, P., Zivari‐Ghader, T., Maharramova, S., Ahmadian, E., Eftekhari, A., Khalilov, R. I., Türksoy, V. A., Rosic, G. L., & Selaković, D. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1148258 · Cited by 31
Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
Zhao, Y., Alexandrov, P. N., & Lukiw, W. J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00059 · Cited by 30
Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
Chen, Y., Wu, T., Li, H., Li, X., Li, Q., Zhu, X., Yu, M., Kuo, S., Huang, F., & Wu, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00044 · Cited by 30
Mohammed, J. S., Nordin, N., Rosli, R., Shaari, K., Bako, H. Y., Saad, N., Noor, N. M., & Razis, A. F. A. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.008 · Cited by 33
D’Antongiovanni, V., Pellegrini, C., Antonioli, L., Benvenuti, L., Salvo, C. D., Flori, L., Piccarducci, R., Daniele, S., Martelli, A., Calderone, V., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.748021 · Cited by 33
Pang, Q., Sun, G., Xin, T., Zhang, R., & Liu, C. (2020) · Pharmacognosy Magazine · doi:10.4103/pm.pm_318_19 · Cited by 28
Liu, X. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s379093 · Cited by 28
Guha, S., Paidi, R. K., Goswami, S., Saha, P., & Biswas, S. C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.021 · Cited by 26
RKIP-Mediated NF-κB Signaling is involved in ELF-MF-mediated improvement in AD rat
Zuo, H., Liu, X., Wang, D., Li, Y., Xu, X., Peng, R., & Song, T. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.28411 · Cited by 27
Ikram, M. A., Jo, M. G., Park, T. J., Kim, M. W., Khan, I., Jo, M. H., & Kim, M. O. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6635552 · Cited by 26
RetractedKhalil, M. N. A., Choucry, M. A., El Senousy, A. S., Hassan, A., El-Marasy, S. A., El Awdan, S. A., & Omar, F. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219378 · Cited by 25
Bankole, O. O., Scambi, I., Parrella, E., Muccilli, M., Bonafede, R., Turano, E., Pizzi, M., & Mariotti, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031047 · Cited by 26
Sajad, M., Kumar, R., & Thakur, S. C. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.04.009 · Cited by 25
Jindal, A., & Nand, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05760-9 · Cited by 27
Zhang, D., Qiao, L., & Fu, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109528 · Cited by 24
Lindsay, A. K., Hickman, D., & Srinivasan, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111405 · Cited by 25
Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease
Srinivasan, M., & Lahiri, D. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0277-5 · Cited by 23
Tian, Y., Milic, J., Monasor, L. S., Chakraborty, R., Wang, S., Yuan, Y., Asare, Y., Behrends, C., Tahirović, S., & Bernhagen, J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04911-8 · Cited by 22
Bhardwaj, S., Grewal, A. K., Singh, S., Dhankar, V., & Jindal, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01502-2 · Cited by 25
Parrella, E., Porrini, V., Scambi, I., Gennari, M. M., Gussago, C., Bankole, O. O., Benarese, M., Mariotti, R., & Pizzi, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1017364 · Cited by 23
Streptocyclinones A and B ameliorate Alzheimer's disease pathological processes in vitro
Alvariño, R., Alonso, E., Lacret, R., Oves‐Costales, D., Genilloud, O., Reyes, F., Alfonso, A., & Botana, L. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.008 · Cited by 21
Luo, W., Han, Y.-S., Meng, P., Yang, Q., Zhao, H.-Q., Ling, J., & Wang, Y. (2020) · Cancer Management and Research · doi:10.2147/cmar.s279800 · Cited by 18
Rosell‐Cardona, C., Amat, C., Griñán‐Ferré, C., Polo, J., Pallàs, M., Pérez‐Bosque, A., Moretó, M., & Miró, L. (2022) · Nutrients · doi:10.3390/nu14112211 · Cited by 22
Li, N., Yao, C., Diao, J., Liu, X., Tang, E., Huang, Q.-S., Zhou, Y., Hu, Y.-G., Li, X.-K., Long, J., et al. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113663 · Cited by 22
Wu, J., Zhang, L., Liu, D., Xia, J., Yang, Y., Tang, F., Chen, L., Ao, H., & Peng, C. Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116955 · Cited by 21
Identification of gene expression predictors of occupational benzene exposure
Schiffman, C., McHale, C. M., Hubbard, A., Zhang, L., Thomas, R., Vermeulen, R. C. H., Li, G., Shen, M., Rappaport, S. M., Yin, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205427 · Cited by 19
Marwarha, G., Schommer, J., Lund, J., Schommer, T., & Ghribi, O. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14292 · Cited by 20
RetractedLiu, Y., Sun, Y., Han, S., Guo, Y., Tian, Q., Ma, Q., & Zhang, S. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00637-3 · Cited by 20
Srinivasan, M., Bayon, B. L., Chopra, N., & Lahiri, D. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160314 · Cited by 17
Lee, J., Jeon, Y.-J., Kang, J.-Y., Lee, S.-K., Lee, H.-D., & Son, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155465 · Cited by 18
Zhang, Y., Ren, Y., Chen, X., Deng, S., & Lü, W. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7232457 · Cited by 18
Ma, Y., Shi, Q., Wang, J., Xiao, K., Sun, J. F., Lv, Y., Guo, M., Zhou, W., Chen, C., Chen, G., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00273 · Cited by 18
Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
Lim, H.-S., Kim, B., Kim, Y. J., & Jeong, S. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.003 · Cited by 17
Naserpour, L., Jalise, S. Z., Khoshandam, M., & Hosseinzadeh, F. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114769 · Cited by 17
Hosseininasab, S. S. M., Ebrahimi, R., Yaghoobpoor, S., Kazemi, K., Khakpour, Y., Hajibeygi, R., Mohamadkhani, A., Fathi, M., Vakili, K. G., Tavasol, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1513095 · Cited by 20
Intrathecal Delivery of ssAAV9-DAO Extends Survival in SOD1G93A ALS Mice
Wang, W., Duan, W., Wang, Y., Wen, D., Liu, Y., Li, Z., Hu, H., Cui, H., Cui, C., Lin, H., et al. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2131-6 · Cited by 16
Genetic Association and Altered Gene Expression of CYBB in Multiple Sclerosis Patients
Cardamone, G., Paraboschi, E. M., Soldà, G., Duga, S., Saarela, J., & Asselta, R. (2018) · Biomedicines · doi:10.3390/biomedicines6040117 · Cited by 16
Ma, F., Cui, Q., & Bai, G. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01975 · Cited by 16
Guglielmotto, M., Repetto, I. E., Monteleone, D., Vasciaveo, V., Franchino, C., Rinaldi, S., Tabaton, M., & Tamagno, E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190494 · Cited by 15
Ibarburu, S., Kovacs, M., Varela, V., Rodriguez‐Duarte, J., Ingold, M., Invernizzi, P., Porcal, W., Arévalo, A. P., Perelmuter, K., Bollati‐Fogolín, M., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00953-z · Cited by 15
Characterization of Inflammatory Signals in BV-2 Microglia in Response to Wnt3a
Li, C., Wu, Y., Huang, M., & Song, X. (2023) · Biomedicines · doi:10.3390/biomedicines11041121 · Cited by 18
Metadata
- Authors
- Srinivasan, M., & Lahiri, D. K.
- Affiliations
- Indiana University (US)
- Indiana University School of Medicine (US)
- Venue
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Published
- 2015-02-04
- Volume
- 19
- Issue
- 4
- Pages
- 471-487
- ISSN
- 1472-8222 (ISSN-L)
- 1744-7631
- PMC
- PMC5873291
- OpenAlex
- W1973257468
- Cited by
- 164
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 11 · 2023: 13 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 16 · 2018: 19 · 2017: 10 · 2016: 10 · 2015: 6
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Expert Opinion on Therapeutic Targets (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Author eBooks
- Funders
- National Institutes of Health (5r21ag042804-02)
- National Institute on Aging (R21-AG042804, 5R21AG042804, 1R21AG047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NF-κB signaling, Alzheimer's disease, multiple sclerosis, neuroinflammation, neurodegeneration, NF-κB inhibitors, neuroprotection, natural compounds, small molecule inhibitors, chronic inflammation
- MeSH terms
- Alzheimer Disease, Animals, Humans, Multiple Sclerosis, Drug Design, Signal Transduction, Up-Regulation, NF-kappa B, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review